Medical
Global CNS Therapeutics Market Opportunities and Forecast 2020-2027
  • DLR468
  • 19 March, 2022
  • Medical Care
  • Pages: 120
  • Global
Global CNS Therapeutics Market, By Disease Type (Infectious Diseases, Neurodegenerative, Autoimmune & Inflammatory Disorders, Genetic Disorders, Cancers, Trauma, Psychiatric Disorders, Anxiety Disorders, Substance Abuse, Mood Disorders, Others), By Application (Hospitals, Clinics, Home Care, Others), and opportunities and forecast 2020-2027

CNS Therapeutics Market Overview

The central nervous system (CNS), which includes the brain and spinal cord, is an important element of the nervous system. The major purpose of the CNS is to integrate information and aid in the coordination and control of body functions. The global CNS Therapeutics market is projected to grow at a significant rate over the stated period. The ageing population, high frequency of various ailments, and increased awareness of CNS therapeutics diseases are projected to drive the global CNS therapeutics market. According to the National Institute on Aging, almost 524 million people were over the age of 65 in 2010, accounting for around 8% of the global population. By 2050, this figure is predicted to reach 1.5 billion, accounting for over 16% of the global population. As people get older, the incidence of CNS illnesses rises.
 
The treatment of CNS disease has a lot of unmet needs. Governments, non-profit organizations, pharmaceutical, and biotechnology companies all around the world have dedicated and raised their research funding budgets over time in order to increase research and clinical breakthroughs in these conditions. During the forecast period, this aspect is expected to propel market expansion. The introduction of numerous medicines with novel mechanisms of action, such as serotonin and norepinephrine reuptake inhibitors, has resulted in the market expansion (SNRIs). Drug patent expiration, on the other hand, is projected to have an impact on total market growth during the projection period.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Disease Type, Application, and Region.
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Pfizer, Inc., Eli Lilly and Company, Inc., Biogen, Inc., GlaxoSmithKline plc, Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG.


Covid-19 Impact on CNS Therapeutics Market
 
In addition, the current CNS Therapeutics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the CNS Therapeutics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
 
CNS Therapeutics Market Segment Overview




According to Disease Type, the Neurodegenerative is one of the largest segments in the global CNS Therapeutics market.  The segment is anticipated to continue its dominance in the forecast period. The increasing frequency of neurological disorders such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease, as well as their high costs, are expected to boost the segment's share throughout the forecast period. Furthermore, the segment is projected to be driven by strong pipeline products for the treatment of neurological disease.

CNS Therapeutics Market, By Disease Type
·       Infectious Diseases
·       Neurodegenerative
·       Autoimmune & Inflammatory Disorders
·       Genetic Disorders
·       Cancers
·       Trauma
·       Psychiatric Disorders
·       Anxiety Disorders
·       Substance Abuse
·       Mood Disorders
·       Others
 
CNS Therapeutics Market, By Application
·       Hospitals
·       Clinics
·       Home Care
·       Others

CNS Therapeutics Market Regional Overview

Geographically, North America is expected to lead the CNS therapeutics market in the forecast period. Factors, such as a high number of reported cases of depression and anxiety as well as the adoption of advanced therapeutics, are projected to intensify the growth of the market in this region.  The CNS therapeutics market in the Asia Pacific is expected to show noteworthy growth in the coming years. This is due to the high rate of incidence of neurodegenerative disorders, increase in awareness regarding mental health, and improvements in healthcare facilities.
 
CNS Therapeutics Market, By Geography
 
·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
CNS Therapeutics Market, Key Players

·       Pfizer, Inc.
·       Eli Lilly and Company, Inc.
·       Biogen, Inc.
·       GlaxoSmithKline plc
·       Otsuka Pharmaceutical Co., Ltd.
·       Johnson & Johnson Services, Inc.
·       Merck & Co., Inc.
·       Novartis AG

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the CNS Therapeutics market?

A. The ageing population, high frequency of various ailments, and increased awareness of CNS therapeutics diseases are projected to drive the global CNS therapeutics market.

Q2. Which Segments are covered in the CNS Therapeutics Market report?

A. Disease Type, Application, and Region. these segments are covered in the CNS Therapeutics market report.

Q3. Which segment is projected to hold the largest share in the CNS Therapeutics Market?

A. Neurodegenerative segment is projected to hold the largest share in the CNS Therapeutics Market.

Q4. Which region holds the largest share in the CNS Therapeutics market?

A. North America held the largest share in the global CNS Therapeutics market.

Q5. Which are the prominent players in the CNS Therapeutics Market?

A. Pfizer, Inc., Eli Lilly and Company, Inc., Biogen, Inc., GlaxoSmithKline plc, Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG. are some key players in the CNS Therapeutics Market.
CNS Therapeutics Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global CNS Therapeutics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Disease Type
        • 5.2.1. Infectious Diseases
        • 5.2.2. Neurodegenerative
        • 5.2.3. Autoimmune & Inflammatory Disorders
        • 5.2.4. Genetic Disorders
        • 5.2.5. Cancers
        • 5.2.6. Trauma
        • 5.2.7. Psychiatric Disorders
        • 5.2.8. Anxiety Disorders
        • 5.2.9. Substance Abuse
        • 5.2.10. Mood Disorders
        • 5.2.11. Others
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Hospitals
        • 5.3.2. Clinics
        • 5.3.3. Home Care
        • 5.3.4. Others
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East and Africa

      6. North America CNS Therapeutics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Disease Type
        • 6.2.1. Infectious Diseases
        • 6.2.2. Neurodegenerative
        • 6.2.3. Autoimmune & Inflammatory Disorders
        • 6.2.4. Genetic Disorders
        • 6.2.5. Cancers
        • 6.2.6. Trauma
        • 6.2.7. Psychiatric Disorders
        • 6.2.8. Anxiety Disorders
        • 6.2.9. Substance Abuse
        • 6.2.10. Mood Disorders
        • 6.2.11. Others
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Hospitals
        • 6.3.2. Clinics
        • 6.3.3. Home Care
        • 6.3.4. Others
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe CNS Therapeutics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Disease Type
        • 7.2.1. Infectious Diseases
        • 7.2.2. Neurodegenerative
        • 7.2.3. Autoimmune & Inflammatory Disorders
        • 7.2.4. Genetic Disorders
        • 7.2.5. Cancers
        • 7.2.6. Trauma
        • 7.2.7. Psychiatric Disorders
        • 7.2.8. Anxiety Disorders
        • 7.2.9. Substance Abuse
        • 7.2.10. Mood Disorders
        • 7.2.11. Others
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Hospitals
        • 7.3.2. Clinics
        • 7.3.3. Home Care
        • 7.3.4. Others
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific CNS Therapeutics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Disease Type
        • 8.2.1. Infectious Diseases
        • 8.2.2. Neurodegenerative
        • 8.2.3. Autoimmune & Inflammatory Disorders
        • 8.2.4. Genetic Disorders
        • 8.2.5. Cancers
        • 8.2.6. Trauma
        • 8.2.7. Psychiatric Disorders
        • 8.2.8. Anxiety Disorders
        • 8.2.9. Substance Abuse
        • 8.2.10. Mood Disorders
        • 8.2.11. Others
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Hospitals
        • 8.3.2. Clinics
        • 8.3.3. Home Care
        • 8.3.4. Others
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa CNS Therapeutics Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Disease Type
        • 9.2.1. Infectious Diseases
        • 9.2.2. Neurodegenerative
        • 9.2.3. Autoimmune & Inflammatory Disorders
        • 9.2.4. Genetic Disorders
        • 9.2.5. Cancers
        • 9.2.6. Trauma
        • 9.2.7. Psychiatric Disorders
        • 9.2.8. Anxiety Disorders
        • 9.2.9. Substance Abuse
        • 9.2.10. Mood Disorders
        • 9.2.11. Others
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Hospitals
        • 9.3.2. Clinics
        • 9.3.3. Home Care
        • 9.3.4. Others
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Pfizer, Inc.
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Eli Lilly and Company, Inc.
      • 10.6. Biogen, Inc.
      • 10.7. GlaxoSmithKline plc
      • 10.8. Otsuka Pharmaceutical Co., Ltd.
      • 10.9. Johnson & Johnson Services, Inc.
      • 10.10. Merck & Co., Inc.
      List of Figures

      Figure 1: Global CNS Therapeutics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global CNS Therapeutics Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America CNS Therapeutics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America CNS Therapeutics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe CNS Therapeutics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific CNS Therapeutics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa CNS Therapeutics Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global CNS Therapeutics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America CNS Therapeutics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe CNS Therapeutics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America CNS Therapeutics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific CNS Therapeutics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa CNS Therapeutics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      [email protected]

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934